Table 1.
Basal characteristics of the two groups.
| Variable | Preoprative Anti-Hypertensive Management (n = 49) | Not Preoperative Anti-Hypertensive Management (n = 14) | p-Value |
|---|---|---|---|
| Age (years) | 56.00 (IQR 49.00–70.25) | 57.00 (IQR 44.00–70.00) | 0.5627 |
| Female sex | 26 (53.06%) | 10 (71.4%) | 0.3583 |
| BMI (kg/m2) | 24.00 (IQR 21.25–26.75) | 27.00 (IQR 24.00–28.00) | 0.0006 |
| Heart disease | 11 (22.45%) | 0 (0.00%) | 0.1147 |
| Hypertension | 8 (16.33%) | 3 (21.43%) | 0.3288 |
| Symptomatic | 28 (57.14%) | 10 (71.43%) | 0.5132 |
| Alpha-blocker | 49 (100.00%) | ||
| Beta-blocker | 28 (57.14%) | ||
| Calcium channel blocker | 2 (4.08%) | ||
| CT-dimension (cm max) | 3.2 (IQR 2.38–8.70) | 4.5 (IQR 3.63–5.88) | 0.0008 |
| Duration of preoperative treatment (days) | 10.00 (8.00–18.00) |
BMI: Body Mass Index; IQR: interquartile range.